AbbVie

AbbVie is an research-based pharmaceutical company that discovers, urldevelops, and markets both biopharmaceuticals and chemically synthesized pharmaceuticals, with a portfolio of more than 40 medicines on the market.  AbbVie has the expertise of a proven pharmaceutical leader and the focus and passion of an entrepreneur and innovator. The result is something rare in health care today – a global biopharmaceutical company that has the ability to discover and advance innovative therapies and meet the health needs of people and societies around the globe.

For more information, please visit AbbVie’s website.

< Back to AmChams

Latest Content

August 26, 2024
U.S. Chamber, AACCLA Condemn Nicaraguan Government’s Move to Shutter AmCham Nicaragua

U.S. Chamber of Commerce Senior Vice President and Head of International John Murphy issued the following statement on the Nicarag...

Read more
August 26, 2024
La Cámara de Comercio de los Estados Unidos y AACCLA condenan la decisión del gobierno nicaragüense de cerrar AmCham Nicaragua

El Vicepresidente Senior de la Cámara de Comercio de Estados Unidos John Murphy emitió la siguiente declaración sobre la decisi...

Read more
February 29, 2024
AACCLA Raises Pillar One Implementation Concerns with OECD

AACCLA wrote to the OECD’s Centre for Tax Policy and Administration to express concerns about local implementation challenge...

Read more
November 2, 2023
Forecast on Latin America and the Caribbean Conference: What You Need to Know

The U.S. Chamber’s Association of American Chambers of Commerce in Latin America and the Caribbean (AACCLA) is hosting its annua...

Read more
November 2, 2023
Inter-American Development Bank “BID for the Americas” Program Launch Remarks

U.S. Chamber of Commerce President and CEO Suzanne P. Clark gave the following remarks at the Inter-American Development Bank “B...

Read more